Portfolio company
Et Cere
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops image processing software to identify brain biotypes from neuroimaging data for clinicians and patients to personalise depression and anxiety treatments.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ceretype Neuromedicine
This company develops functional MRI and AI-powered biomarker platforms for pharmaceutical developers and clinicians to measure brain circuitry in psychiatric and neurological diseases.
BrainQuant
This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.
PsyScale
This company develops clinical AI software to provide structured treatment for anxiety and depression for commissioners, healthcare providers and insurers.
RebrAIn
The company develops artificial intelligence software to help neurosurgeons identify optimal brain targets for deep brain stimulation and lesioning treatments.
neurocare
This company develops neuromodulation devices and digital therapy platforms for clinicians and researchers treating psychological and neurological conditions.
Hemispheric
This company develops artificial intelligence models and platforms for decoding non-invasive brain signals to assist clinicians and researchers with neurological and psychiatric diagnoses.
Alto Neuroscience
This biopharmaceutical company develops precision medicines for patients with neuropsychiatric conditions by using an artificial intelligence platform to analyse brain-based biomarkers.
Cercare Medical
This company develops AI-powered perfusion imaging software for CT and MRI scans to assist clinicians in diagnosing neurological conditions like stroke and oncology.
